Lighting Intervention for Cancer-related Fatigue
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan Rogel Cancer Center
- Study ID
- NCT04827446
- Status
- Completed
Conditions
- Breast Cancer
- Fatigue
- Hematologic Malignancy
- Prostate Cancer
- Survivorship
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Wearable Sensor — OTHERPatient is given a wearable device to wear for 12 weeks.
- Blue-blocking glasses — OTHERPatient is given blue-blocking glasses to wear at instructed times.
- Clear glasses — OTHERPatient is given glasses that block no visible light.
- Full SYNC app — OTHERPatient downloads the SYNC app and is given light interventions designed to have a targeted, personalized effect on the circadian clock.
- "Dummy" SYNC app — OTHERPatient downloads the SYNC app and is given light interventions designed to have minimal impact on the circadian clock.
Study Details
Fatigue is a major problem for cancer patients, and one that can persist long after treatment ends. Recent work has demonstrated that light therapy may mitigate or reduce fatigue levels in both cancer patients and cancer survivors. This protocol seeks to assess how lighting interventions distributed through a mobile app affect fatigue, sleep, and quality of life across three populations of cancer patients: breast cancer and prostate cancer, and patients who have undergone autologous hematopoietic stem cell transplant (HSCT). Participants will be randomized 1:1 to either the interventional SYNC app or to a control app.
Key Dates
- Start date
- Jul 15, 2021
- Status verified
- Jun 2025
- Primary completion
- Mar 9, 2023
- Completion
- Mar 9, 2023
Study Design
- Enrollment
- 139 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Intervention ArmLight intervention delivered through SYNC app + blue-light blocking glasses.
- Active Comparator: Control ArmPlacebo light intervention delivered through SYNC app + clear glasses.
Primary Outcome Measure
Change in Fatigue Assessed With Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) Fatigue 4a [ Time Frame: 11 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | - |
Find similar trials in Ann Arbor, MI
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama